Cenduit India services

Formed in May 2007, Cenduit originated as a joint venture between two leading clinical development and clinical supply chain organizations: IQVIA and Thermo Fisher Scientific. Both companies recognized the increasing demand for patient randomization and drug supply management services and seized the opportunity to create a specialized IRT solutions provider. Cenduit, an IQVIA business, is a recognized industry leader in the IRT market and eClinical field, and have implemented over 1,600 clinical trials requiring patient randomization, clinical supply distribution and returns/destruction accountability. In over 10 years of operation, Cenduit has worked closely with more than 100 global biopharmaceutical companies and has deep integrations with many CROs, across all geographies. We have successful ongoing relationships with leading clinical supply packaging and distribution organizations, as well as extensive integrations with eClinical systems such as EDC, CTMS and Labs. We are IRT focused - dedicated to quality-first and patient outcomes. Our core expertise is strongly focused on randomization of patients and the management of clinical trials supplies. Today’s Interactive Response Technology (IRT) systems are increasingly complex. Flexible and configurable IRT matters - with IRT data as the source of record for recruitment, clinical trial drop-out rates, patient visits, and other crucial data. Choose a platform that’s user-friendly, mobile-ready, and comprehensive - embedded in quality, flexibility and expertise. Choose comfort with complex therapeutic expertise in today’s risk-based eClinical environment. Combining the right technology, subject matter expertise and commitment to service - we empower clinical trials to deliver patient outcomes. Deep clinical and supply chain knowledge drives innovation and provides clients with control over their Randomization and Trial Supply Management (RTSM) processes. Our innovative suite of tools drives distinctive levels of quality control, site efficiency and patient compliance.